Longbin Liu

4.6k total citations · 1 hit paper
84 papers, 2.5k citations indexed

About

Longbin Liu is a scholar working on Molecular Biology, Organic Chemistry and Aerospace Engineering. According to data from OpenAlex, Longbin Liu has authored 84 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Organic Chemistry and 16 papers in Aerospace Engineering. Recurrent topics in Longbin Liu's work include Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (8 papers) and Synthesis and Properties of Aromatic Compounds (6 papers). Longbin Liu is often cited by papers focused on Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (8 papers) and Synthesis and Properties of Aromatic Compounds (6 papers). Longbin Liu collaborates with scholars based in United States, China and Belgium. Longbin Liu's co-authors include Robert E. Ireland, Thomas J. Katz, Bingwei Yang, Michael K. Poindexter, Celia Dominguez, Ning Xi, Nikolaos D. Willmore, Paul J. Reider, Mike Frohn and Larry L. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Longbin Liu

80 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An improved procedure for the preparation of the Dess-Martin periodinane

1993 585 citations Longbin Liu et al. profile →

Peers

Countries citing papers authored by Longbin Liu

Since Specialization

Citations

This map shows the geographic impact of Longbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbin Liu more than expected).

Fields of papers citing papers by Longbin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbin Liu. The network helps show where Longbin Liu may publish in the future.

Co-authorship network of co-authors of Longbin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Longbin Liu. A scholar is included among the top collaborators of Longbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longbin Liu. Longbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An LSTM-driven thermoelectric coupling response prediction method for shape memory alloy actuators 2025 ·Scientific Reports ·(unknown), Longbin Liu, Shifeng Zhang, Mingkun Li	1
2	In Vivo PET Imaging of [ ¹⁸ F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington Disease 2025 ·Journal of Nuclear Medicine ·(unknown), Filipe Elvas, Alan Miranda, (unknown), Jeroen Verhaeghe, (unknown), Robert K. Doot, Vinod Khetarpal, Jonathan Bard, Longbin Liu, Steven Staelens, Daniele Bertoglio	0
3	Design of insulation support system of 120 keV positive ion source accelerator 2024 ·Plasma Science and Technology ·(unknown), Yahong Xie, Yuming Gu, (unknown), Longbin Liu, (unknown), Jianglong Wei, Chundong Hu	1
4	In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using¹¹C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease 2023 ·Journal of Nuclear Medicine ·Daniele Bertoglio, Alison R. Weiss, William A. Liguore, Lauren Martin, Theodore R. Hobbs, (unknown), Sathya Srinivasan, Celia Dominguez, Ignacio Muñoz-Sanjuán, Vinod Khetarpal, Jeroen Verhaeghe, Steven Staelens, Jeanne Link, Longbin Liu, Jonathan Bard, Jodi L. McBride	8
5	Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington’s disease 2023 ·Scientific Reports ·Mohit H. Adhikari, (unknown), Roger Cachope, Haiying Tang, Longbin Liu, Georgios A. Keliris, Ignacio Muñoz-Sanjuán, Dorian Pustina, Annemie Van der Linden, Marleen Verhoye	4
6	Resting-state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease 2023 ·Neurobiology of Disease ·(unknown), Mohit H. Adhikari, Johan Van Audekerke, (unknown), Dorian Pustina, Roger Cachope, Haiying Tang, Longbin Liu, Ignacio Muñoz-Sanjuán, Annemie Van der Linden, Marleen Verhoye	12
7	Failure properties of flexible composite under trouser-shaped tests 2022 ·Journal of Composite Materials ·(unknown), Yongfeng Li, Longbin Liu	2
8	Validation, kinetic modeling, and test-retest reproducibility of [¹⁸F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice 2022 ·Journal of Cerebral Blood Flow & Metabolism ·Daniele Bertoglio, (unknown), (unknown), Alan Miranda, Sigrid Stroobants, Yuchuan Wang, Celia Dominguez, Ignacio Muñoz-Sanjuán, Jonathan Bard, Longbin Liu, Jeroen Verhaeghe, Steven Staelens	15
9	Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D1R Radioligand [11C]SCH23390 in Healthy and Diseased Mice 2020 ·Molecular Imaging and Biology ·Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, Leonie Wyffels, Sigrid Stroobants, Celia Dominguez, Ignacio Muñoz-Sanjuán, Mette Skinbjerg, Longbin Liu, Steven Staelens	4
10	The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement 2020 ·Bioorganic & Medicinal Chemistry Letters ·Michael Frohn, Longbin Liu, Aaron C. Siegmund, Wenyuan Qian, Albert Amegadzie, Ning Chen, (unknown), Dean Hickman, Stephen Wood, Paul H. Wen, Michael D. Bartberger, Douglas A. Whittington, Jennifer R. Allen, Matthew P. Bourbeau	4
11	Polyphenols and Polypeptides in Chinese Rice Wine Inhibit Homocysteine-induced Proliferation and Migration of Vascular Smooth Muscle Cells 2016 ·Journal of Cardiovascular Pharmacology ·Liping Meng, Longbin Liu, (unknown), Sunlei Pan, Xiaoya Zhai, (unknown), Yan Guo, Zheng Ji, Jufang Chi, Fang Peng, Hangyuan Guo	25
12	Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling 2016 ·Bioorganic & Medicinal Chemistry ·Longbin Liu, Matthew R. Lee, Joseph L. Kim, Douglas A. Whittington, Howard Bregman, Zihao Hua, Richard T. Lewis, Matthew W. Martin, Nobuko Nishimura, Michele Potashman, Kevin Yang, (unknown), (unknown), Linda F. Epstein, Carol Babij, Manory Fernando, Josette Carnahan, Mark H. Norman	13
13	Rosuvastatin may Modulate Insulin Signaling and Inhibit Atherogenesis Beyond its Plasma Cholesterol-Lowering Effect in Insulin-Resistant Mice 2012 ·Cardiovascular Drugs and Therapy ·Hangyuan Guo, (unknown), Weiliang Tang, (unknown), Longbin Liu, (unknown), Zheng Ji, Xiaoya Zhai, Fang Peng	6
14	Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives 2012 ·Journal of Medicinal Chemistry ·Mark H. Norman, Longbin Liu, Matthew Lee, Ning Xi, I.M. Fellows, Noel D. D’Angelo, Celia Dominguez, Karen Rex, Steven F. Bellon, Tae‐Seong Kim, Isabelle Dussault	90
15	Rosuvastatin Inhibits MMP-2 Expression and Limits the Progression of Atherosclerosis in LDLR-deficient Mice 2009 ·Archives of Medical Research ·Hangyuan Guo, Yafei Shi, Longbin Liu, Aijing Sun, (unknown), (unknown)	28
16	Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice 2009 ·Coronary Artery Disease ·Hangyuan Guo, (unknown), Aijing Sun, Longbin Liu, Yafei Shi	5
17	High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38 α Kinase Inhibitors Using Cell-Based Assays 2006 ·Assay and Drug Development Technologies ·Sandra L. Ross, Teresa C. Chen, Violeta Yu, Yanyan Tudor, Dawei Zhang, Longbin Liu, Nuria Tamayo, Celia Dominguez, David Powers	15
18	Platelet hyperfunction exists in both acute non-haemorrhagic and haemorrhagic stroke 1994 ·Thrombosis Research ·Longbin Liu, Zhicheng Lin, Zhiwei Shen, Guangsen Zhang, (unknown), (unknown)	13
19	Elevated Plasma Levels of Vwf:Ag in Hyperthyroidism are Mediated Through Beta-Adrenergic Receptors 1993 ·Endocrine Research ·Longbin Liu, Xiangbin Wang, (unknown), (unknown)	29
20	Changes of von Willebrand factor and antithrombin III levels in acute stroke: Difference between thrombotic and haemorrhagic stroke 1993 ·Thrombosis Research ·Longbin Liu, (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact